EDGAR Filing Documents for 0001564590-20-002829

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001564590-20-002829

Filing Date

2020-01-31

Accepted

2020-01-31 06:01:56

Documents

Period of Report

2020-01-31

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	bntc-6k_20191231.htm	6-K	17849
2	EX-99.1	bntc-ex991_6.htm	EX-99.1	15319
3	EX-99.2	bntc-ex992_7.htm	EX-99.2	175194
4	GRAPHIC	gmfkkjqvat2d000001.jpg	GRAPHIC	4664
5	GRAPHIC	gii35rfbjgyk000001.jpg	GRAPHIC	1517
	Complete submission text file	0001564590-20-002829.txt		218144

Mailing Address LEVEL 14 114 WILLIAM ST MELBOURNE VIC C3 3000

Business Address LEVEL 14 114 WILLIAM ST MELBOURNE VIC C3 3000 3 8692-7222

Benitec Biopharma LTD/ADR (Filer) CIK: 0001552795 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-37518 | Film No.: 20563187
SIC: 2834 Pharmaceutical Preparations